{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:35:47Z","timestamp":1787330147004,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07441-3","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:49:09Z","timestamp":1787327349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and treatment strategies of brainstem lesion in children with neurofibromatosis type 1"],"prefix":"10.1007","volume":"42","author":[{"given":"Han","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yongqiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Hangzhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"4","key":"7441_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/14737175.2024.2324117","volume":"24","author":"N Kerashvili","year":"2024","unstructured":"Kerashvili N, Gutmann DH (2024) The management of neurofibromatosis type 1 (NF1) in children and adolescents. Expert Rev Neurother 24(4):409\u2013420. https:\/\/doi.org\/10.1080\/14737175.2024.2324117","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"7441_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07452-y","volume":"9","author":"JP Brosseau","year":"2018","unstructured":"Brosseau JP, Liao CP, Wang Y et al (2018) NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nat Commun 9(1):5014. https:\/\/doi.org\/10.1038\/s41467-018-07452-y","journal-title":"Nat Commun"},{"issue":"16","key":"7441_CR3","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1212\/WNL.0000000000003881","volume":"88","author":"J Mahdi","year":"2017","unstructured":"Mahdi J, Shah AC, Sato A et al (2017) A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology 88(16):1584\u20131589. https:\/\/doi.org\/10.1212\/WNL.0000000000003881","journal-title":"Neurology"},{"issue":"Pt 1","key":"7441_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/brain\/awg016","volume":"126","author":"JS Guillamo","year":"2003","unstructured":"Guillamo JS, Cr\u00e9ange A, Kalifa C et al (2003) Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126(Pt 1):152\u2013160. https:\/\/doi.org\/10.1093\/brain\/awg016","journal-title":"Brain"},{"issue":"4","key":"7441_CR5","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1227\/01.NEU.0000298904.63635.2D","volume":"61","author":"NJ Ullrich","year":"2007","unstructured":"Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L (2007) Brainstem lesions in neurofibromatosis type 1. Neurosurgery 61(4):762\u2013767. https:\/\/doi.org\/10.1227\/01.NEU.0000298904.63635.2D","journal-title":"Neurosurgery"},{"issue":"6","key":"7441_CR6","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1212\/wnl.46.6.1652","volume":"46","author":"IF Pollack","year":"1996","unstructured":"Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46(6):1652\u20131660. https:\/\/doi.org\/10.1212\/wnl.46.6.1652","journal-title":"Neurology"},{"issue":"8","key":"7441_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1212\/wnl.54.8.1646","volume":"54","author":"K DeBella","year":"2000","unstructured":"DeBella K, Poskitt K, Szudek J, Friedman JM (2000) Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54(8):1646\u20131651. https:\/\/doi.org\/10.1212\/wnl.54.8.1646","journal-title":"Neurology"},{"key":"7441_CR8","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.wneu.2024.10.001","volume":"192","author":"Y Han","year":"2024","unstructured":"Han Y, Wang H, Huang Y (2024) T2 hyperintensities in children with neurofibromatosis type 1. World Neurosurg 192:e480\u2013e485. https:\/\/doi.org\/10.1016\/j.wneu.2024.10.001","journal-title":"World Neurosurg"},{"issue":"8","key":"7441_CR9","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1212\/WNL.0000000000009458","volume":"95","author":"J Mahdi","year":"2020","unstructured":"Mahdi J, Goyal MS, Griffith J, Morris SM, Gutmann DH (2020) Nonoptic pathway tumors in children with neurofibromatosis type 1. Neurology 95(8):e1052\u2013e1059. https:\/\/doi.org\/10.1212\/WNL.0000000000009458","journal-title":"Neurology"},{"issue":"10","key":"7441_CR10","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00381-020-04697-1","volume":"36","author":"B Shofty","year":"2020","unstructured":"Shofty B, Ben Sira L, Constantini S (2020) Neurofibromatosis 1-associated optic pathway gliomas. Childs Nerv Syst 36(10):2351\u20132361. https:\/\/doi.org\/10.1007\/s00381-020-04697-1","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"7441_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s002340050484","volume":"39","author":"LT Bilaniuk","year":"1997","unstructured":"Bilaniuk LT, Molloy PT, Zimmerman RA et al (1997) Neurofibromatosis type 1: brain stem tumours. Neuroradiology 39(9):642\u2013653. https:\/\/doi.org\/10.1007\/s002340050484","journal-title":"Neuroradiology"},{"issue":"4","key":"7441_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00381-019-04463-y","volume":"36","author":"M Giagnacovo","year":"2020","unstructured":"Giagnacovo M, Antonelli M, Biassoni V et al (2020) Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG). Childs Nerv Syst 36(4):697\u2013704. https:\/\/doi.org\/10.1007\/s00381-019-04463-y","journal-title":"Childs Nerv Syst"},{"key":"7441_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216876","volume":"590","author":"LJ Weisbrod","year":"2024","unstructured":"Weisbrod LJ, Thiraviyam A, Vengoji R et al (2024) Diffuse intrinsic pontine glioma (DIPG): a review of current and emerging treatment strategies. Cancer Lett 590:216876. https:\/\/doi.org\/10.1016\/j.canlet.2024.216876","journal-title":"Cancer Lett"},{"issue":"5","key":"7441_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000192","volume":"3","author":"C Anastasaki","year":"2017","unstructured":"Anastasaki C, Morris SM, Gao F, Gutmann DH (2017) Children with 5\u2019-end NF1 gene mutations are more likely to have glioma. Neurol Genet 3(5):e192. https:\/\/doi.org\/10.1212\/NXG.0000000000000192","journal-title":"Neurol Genet"},{"issue":"1","key":"7441_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska M, Chen Y, Callens T et al (2018) Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848. Am J Hum Genet 102(1):69\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2017.12.001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"7441_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-6-12","volume":"6","author":"A Alkindy","year":"2012","unstructured":"Alkindy A, Chuzhanova N, Kini U, Cooper DN, Upadhyaya M (2012) Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Hum Genomics 6(1):12. https:\/\/doi.org\/10.1186\/1479-7364-6-12","journal-title":"Hum Genomics"},{"issue":"4","key":"7441_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ejpn.2018.02.012","volume":"22","author":"S Tritt","year":"2018","unstructured":"Tritt S, Hillenbrand N, Liesirova K, Moein G, Kieslich M, Porto L (2018) Comparison of the detectability of UBOs in Neurofibromatosis Type I patients with proton density-weighted and FLAIR sequences in 3T MRI. Eur J Paediatr Neurol 22(4):615\u2013619. https:\/\/doi.org\/10.1016\/j.ejpn.2018.02.012","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"7441_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00247-007-0712-x","volume":"38","author":"JR Lopes Ferraz Filho","year":"2008","unstructured":"Lopes Ferraz Filho JR, Munis MP, Soares Souza A, Sanches RA, Goloni-Bertollo EM, Pavarino-Bertelli EC (2008) Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 38(3):305\u2013310. https:\/\/doi.org\/10.1007\/s00247-007-0712-x","journal-title":"Pediatr Radiol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07441-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:49:10Z","timestamp":1787327350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07441-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7441"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07441-3","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"342"}}